Comparison of Helicobacter pylori eradication rates between 7 and 14 days of tailored therapy according to clarithromycin resistance test: A randomized, multicenter, non‐inferiority study

Documenti analoghi

• Impact of mixed‐infection rate of clarithromycin‐susceptible and clarithromycin‐resistant Helicobacter pylori strains on the success rate of clarithromycin‐based eradication treatment
  di: Momoko Tsuda, et al.
  Pubblicazione: (2024)
• 14‐day tailored PCR‐guided triple therapy versus 14‐day non‐Bismuth concomitant quadruple therapy for Helicobacter pylori eradication: A multicenter, open‐label randomized noninferiority controlled trial
  di: Aurelien Amiot, et al.
  Pubblicazione: (2024)
• Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review
  di: Xiaoqi Wu, et al.
  Pubblicazione: (2024)
• Application of cefuroxime in the eradication therapy of Helicobacter pylori infection: A review article
  di: Changmin Mi, et al.
  Pubblicazione: (2024)
• Risk of map‐like redness development after eradication therapy for Helicobacter pylori infection
  di: Sho Matsumoto, et al.
  Pubblicazione: (2024)